Reference health

Discovery of a potent and selective small molecule hGPR91 antagonist

https://doi.org/10.1016/j.bmcl.2011.04.091

21/21 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 21 checked references that resolve

resolves10.1038/nature02488

Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors

resolves10.1007/s11302-004-5071-6

The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids

resolves10.1016/j.cell.2008.08.040

Anatomical Profiling of G Protein-Coupled Receptor Expression

resolves10.1189/jlb.1008618

The role of the GPR91 ligand succinate in hematopoiesis

resolves10.1038/nm.1873

The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis

resolves10.1038/429143a

Orphan detectors of metabolism

resolves10.1093/ndt/gfn377

Activation of the renal renin-angiotensin system in diabetes--new concepts

resolves10.1681/ASN.2008070740

Activation of the Succinate Receptor GPR91 in Macula Densa Cells Causes Renin Release

resolves10.1038/ki.2010.333

High glucose and renin release: the role of succinate and GPR91

resolves10.1016/j.jhep.2007.03.016

Succinate is a paracrine signal for liver damage

resolves10.1038/ni.1657

Triggering the succinate receptor GPR91 on dendritic cells enhances immunity

resolves10.1007/s10633-009-9201-x

Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy

resolves10.1016/j.bmcl.2006.01.112

5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists

resolves10.1021/jm061094b

Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B <sub>1</sub> Receptor Antagonists

resolves10.1016/S0960-894X(01)00687-4

Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide

resolves10.1021/jo026203i

Highly Regioselective Friedländer Annulations with Unmodified Ketones Employing Novel Amine Catalysts: Syntheses of 2-Substituted Quinolines, 1,8-Naphthyridines, and Related Heterocycles

resolves10.1021/jo00168a007

Regiospecific electrophilic substitution of aminopyridines: ortho lithiation of 2-, 3-, and 4-(pivaloylamino)pyridines

resolves10.1081/SCC-100104071

HIGHLY EFFICIENT SYNTHESIS OF 2-AMINO-3-PYRIDINECARBOXALDEHYDE

resolves10.1016/S0022-1139(02)00172-0

Syntheses and insecticidal activity of new 2-(5-(trifluoromethyl)pyridyloxymethyl)-1,3,4-oxadiazoles

resolves10.3987/COM-06-10699

New Efficient Blue-greenish Electroluminescent Materials of 1,3,4-Oxadiazole-based Pyrazole Derivatives

resolves10.1021/ol035778e

Solution and Solid-Supported Synthesis of 3,4,5-Trisubstituted 1,2,4-Triazole-Based Peptidomimetics

The 5 references without a DOI — listed, not checked

no DOI — not checked10.1016/j.bmcl.2011.04.091_b0035

no DOI — not checked10.1016/j.bmcl.2011.04.091_b0045

no DOI — not checkedWe are not aware of any prior art literature of GPR91 antagonist. However, there are patent applications claiming method of screening of drug candidates modulating GPR91 and the method of treatment to various therapeutic indications. Please see, (a) Li, K.; Wang, S.-W.; Hu, G.; Yao, Z. PCT international publication no. WO 2005/010152 A2. (b) Golz, S.; Brüggemeier, U.; Geerts, A.; Summer, H. PCT international publication no. WO 2005/050220 A1. (c) Carballido Herrera, J. M.; Lametschwandtner, G.; Werner, G.; Rot, A. PCT international publication no. WO 2006/117193 A2. (d) Hakak, Y.; Liu, L.; Bruinsma, K. PCT international publication no. WO 2009/011885 A1.

no DOI — not checked(b) Wood, M. R.; Kuduk, S. D.; Bock, M. G.; Chang, R. K. US Patent application publication no. US 2006/0128765 A1.

no DOI — not checked(c) Wood, M. R.; Su, D.-S.; Wai, J. M.-C. US Patent application publication no. US 2006/0173023 A1.

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.bmcl.2011.04.091"><img src="https://citestamp.com/citestamped/10.1016/j.bmcl.2011.04.091/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.bmcl.2011.04.091/badge.svg)](https://citestamp.com/citestamped/10.1016/j.bmcl.2011.04.091)